Rekah Pharmaceutical Industry Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
REKA
IL0010810096
Pharmaceuticals
Sales 2022 | 292M 76.81M | Sales 2023 | 322M 84.5M | Capitalization | 169M 44.32M |
---|---|---|---|---|---|
Net income 2022 | -2M -525K | Net income 2023 | -6M -1.58M | EV / Sales 2022 | 1.1 x |
Net Debt 2022 | 145M 38.2M | Net Debt 2023 | 166M 43.72M | EV / Sales 2023 | 1.04 x |
P/E ratio 2022 |
-85.5
x | P/E ratio 2023 |
-24.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 80 | 93-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 18-10-31 |
Director/Board Member | 78 | 93-08-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15-04-14 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15-04-14 |
Avraham Bigger
CHM | Chairman | 77 | 15-04-14 |
1st Jan change | Capi. | |
---|---|---|
+16.62% | 70.95B | |
+2.99% | 25.25B | |
+5.38% | 8.67B | |
+6.46% | 8.16B | |
-21.01% | 7.91B | |
+0.06% | 4.51B | |
+17.12% | 4.31B | |
-0.14% | 4.07B | |
-3.64% | 3.84B |